Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (251K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (59)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Johnson, C. A.
Right arrow Articles by Turner, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, C. A.
Right arrow Articles by Turner, B. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research Pages 994-1001


Distinctive patterns of histone H4 acetylation are associated with defined sequence elements within both heterochromatic and euchromatic regions of the human genome
Introduction
Materials And Methods
   Polyclonal antisera to acetylated histone H4 isoforms
   Cultured cells
   Preparation of chromatin from lymphoblastoid cells
   Immunoprecipitation of chromatin from cultured cells
   Slot-blot analysis and Southern hybridizations
   DNA probes
Results
   Immunoprecipitation results in selective enrichment of acetylated chromatin
   H4 acetylation associated with coding DNA in euchromatin
   H4 acetylation associated with simple repeat DNA and coding DNA within or adjacent to such repeats
   SINE-rich and LINE-rich chromatin differ in H4 acetylation
Discussion
   Specificity of histone acetylation in human chromatin
   Histone acetylation in coding and non-coding regions
Acknowledgements
References


Distinctive patterns of histone H4 acetylation are associated with defined sequence elements within both heterochromatic and euchromatic regions of the human genome

Distinctive patterns of histone H4 acetylation are associated with defined sequence elements within both heterochromatic and euchromatic regions of the human genome Colin A. Johnson, Laura P. O'Neill, Arthur Mitchell1 and Bryan M. Turner*

Chromatin and Gene Expression Group, Department of Anatomy, The Medical School, University of Birmingham, Birmingham B15 2TT, UK and 1MRC Human Genetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK

Received October 14, 1997; Revised and Accepted December 11, 1997

ABSTRACT

The pattern of histone H4 acetylation in different genomic regions has been investigated by immunoprecipitating oligonucleosomes from a human lymphoblastoid cell line with antibodies to H4 acetylated at lysines 5, 8, 12 or 16. DNA from antibody-bound or unbound chromatin was assayed by slot blotting. Pol I and pol II transcribed genes located in euchromatin were shown to have levels of H4 acetylation at lysines 5, 8 and 12 equivalent to those in input chromatin, but to be slightly enriched in H4 acetylated at lysine 16. In no case did the acetylation level correlate with actual or potential transcriptional activity. All acetylated histone H4 isoforms were depleted in non-coding, simple repeat DNA in heterochromatin, though the extent of depletion varied with the type of heterochromatin and with the isoform. Two single copy genes that map within or adjacent to blocks of paracentric heterochromatin are depleted in H4 acetylated at lysines 5, 8 and 12, but not 16. Consensus sequences of repetitive elements of the Alu family (SINES, enriched in R bands) were associated with H4 that was more highly acetylated at all four lysines than input chromatin, while H4 associated with KpnI elements (LINES, enriched in G bands) was significantly underacetylated.

INTRODUCTION

The nucleosome core particle consists of 146 bp of DNA wrapped around an octameric complex of core histones (two each of H2A, H2B, H3 and H4) and is the basic structural unit of chromatin in all eukaryotic cells (1). In addition to this highly conserved structural role, nucleosomes are now known to be actively involved in the regulation of several fundamental cellular processes, including transcription, DNA replication and cell cycle progression (2-5). Regulatory functions are mediated, at least in part, by fine adjustments to the nucleosome through enzyme catalysed, post-translational modifications of the core histones. These include acetylation, phosphorylation, ADP ribosylation, ubiquitination and glycosylation (6,7).

Histone acetylation is one of the most frequent modifications and certainly the most extensively studied. It is ubiquitous in plants and animals. Acetylation of the core histones occurs at the [epsilon] amino groups of conserved lysine residues in the N-terminal region of each protein and is catalysed by a family of enzymes, the histone acetyltransferases (HATs). The modification is chemically stable but metabolically reversible through the activities of a second enzyme family, the histone deacetylases (HDACs). Both enzymatic activities are often found to be present in complex, multi-subunit assemblies that differ in substrate specificity, susceptibility to inhibitors and intracellular location (8-10). Genes encoding subunits of both HATs and HDACs have been cloned recently and shown to have homology to (or complete identity with) known regulators of transcription (8,11,12).

We have proposed that, because histone acetylation is involved in such a variety of cellular processes, it is likely that different functions will require selective acetylation of specific histones and even of specific lysine residues on individual histones (13,14). Direct support for this idea has come from the demonstration that H4 specifically diacetylated at lysines 5 and 12 is involved in post-replication chromatin assembly (15) and by recent studies on purified HATs showing that, in vitro at least, they are highly selective in the histone lysines they acetylate. In order to provide a more general means for testing this proposition we have prepared antisera that can distinguish histone isoforms acetylated at specific lysine residues (16,17). These have been used both for immunofluorescence microscopy of polytene and metaphase chromosomes (18-22) and immunoprecipitation of chromatin fragments (23). The former permits visualization of histone acetylation across relatively large chromatin domains and has shown that defined regions, and even whole chromosomes, can show characteristic patterns of histone acetylation (20), sometimes involving acetylation of specific lysines (18). The latter can be used to analyse acetylation of histones associated with particular genes or subregions within genes and can be used to relate histone acetylation to genomic structure and function, including actual or potential transcriptional activity (23).

In the present report we describe the use of antibodies specific for H4 acetylated at lysines 5, 8, 12 or 16 to immunoprecipitate oligonucleosomes from a human diploid lymphoblastoid cell line and thereby map acetylated H4 isoforms to defined regions of the genome. The results show that different regions are packaged as chromatin with widely differing levels of H4 acetylation. A striking finding is that GC-rich retroposon-derived sequences (SINES), characteristic of chromosomal R bands, are enriched in acetylated chromatin fractions, while GC-poor sequences (LINES), characteristic of G bands, are depleted. Coding DNA, irrespective of its transcriptional status, shows only a modest increase in acetylation (and only at lysine 16) compared with bulk chromatin. The results are consistent with immunofluorescence studies with antisera to acetylated H4 in which R bands label more strongly than G bands, but show that this differential labelling is due to differences in SINE/LINE content rather than coding DNA per se.

MATERIALS AND METHODS

Polyclonal antisera to acetylated histone H4 isoforms

Polyclonal antisera to acetylated H4 were raised in rabbits by immunization with synthetic peptides which correspond to the sequence in the N-terminal domain of histone H4 containing acetyl-lysine residues at defined positions. The preparation and characterization of these antisera have been described in detail elsewhere (16-18).For immunoprecipitation of unfixed chromatin each antiserum was affinity purified, as described previously (16-18,23)

Cultured cells

Normal B lymphocytes can be transformed and immortalized by infection with Epstein-Barr virus (24,25).The female lymphoblastoid cell line used in this study was provided by Prof. A.M.R.Taylor (University of Birmingham, UK) and had no detectable chromosomal aberrations. Cells were grown in RPMI medium (Gibco BRL) supplemented with 8% foetal calf serum (Gibco BRL) in an atmosphere of 5% CO2 in air.

Preparation of chromatin from lymphoblastoid cells

Chromatin was isolated from lymphoblastoid cells as described previously (23). Cells were grown to a density of ~106 cells/ml and labelled for 16 h with 0.5 µCi/ml [3H]thymidine (Amersham). Each immunoprecipitation experiment required 108 cells for sufficient yields of material. All steps were performed at 4°C in the presence of 5 mM sodium butyrate. Cells were harvested by centrifugation, washed, lysed with 0.5% Tween 40 and homogenized in a Dounce all-glass homogenizer with the A pestle. Homogenates were applied to a discontinuous 25-50% (w/v) sucrose gradient to isolate nuclei. The nuclear pellet was resuspended in digestion buffer (0.32 M sucrose, 50 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 1 mM CaCl2, 0.1 mM PMSF, 5 mM sodium butyrate) to a final concentration of 0.5 mg DNA/ml (as determined by absorbance at [lambda]260 nm).

Chromatin was released from nuclei by digestion with micrococcal nuclease (final concentration 75 U/ml; Pharmacia) at 37°C for 5 min. Digestion was stopped by addition of Na2EDTA to a final concentration of 5 mM and cooling on ice. The preparation was centrifuged (11 600 g, 10 min) and the supernatant designated S1. The pellet was resuspended in lysis buffer (1 mM Tris-HCl, pH 7.4, 0.2 mM Na2EDTA, 0.2 mM PMSF, 5 mM sodium butyrate), dialysed extensively and centrifuged to yield a solubilized chromatin fraction, designated S2. The extent of nuclease digestion was assessed by 1.2% agarose gel electrophoresis (26).Fractions S1 and S2 were pooled to form the input material for immunoprecipitations.

Immunoprecipitation of chromatin from cultured cells

The procedure for immunoprecipitation of unfixed chromatin has been described in detail elsewhere (23). All buffers contained 5 mM sodium butyrate. Briefly, affinity-purified antiserum (100-200 µl, containing 50-100 µg IgG) was added to 100-200 µg unfixed chromatin and the final volume made up to 1 ml with incubation buffer (50 mM NaCl, 20 mM Tris-HCl, pH 7.5, 20 mM sodium butyrate, 5 mM Na2EDTA, 0.1 mM PMSF). The mixture was incubated for 16 h at 4°C, then treated with 200 µl 50% (v/w) slurry of protein A-Sepharose (Pharmacia) for 3 h at room temperature. After centrifugation the supernatant, containing antibody-unbound material, was retained and the protein A-Sepharose pellet was washed three times with wash buffer (50 mM Tris-HCl, pH 7.5, 10 mM EDTA, 5 mM sodium butyrate) containing increasing concentrations (50, 100 and 150 mM) of NaCl. Antibody-bound material was eluted from the protein A-Sepharose by treatment with 250 µl 1% SDS in incubation buffer for 15 min at room temperature. SDS in the bound fraction was then diluted to 0.5% with incubation buffer, to a final volume of 500 µl.

DNA was obtained from the input, unbound and bound fractions by two phenol/chloroform extractions and one chloroform extraction. DNA was ethanol precipitated using 5 µg glycogen as carrier and dissolved in 250 µl TE buffer (10 mM Tris-HCl, 2 mM Na2EDTA, pH 7.4). All DNA samples were analysed by 1.2% agarose gel electrophoresis and incorporation of [3H]thymidine was determined by scintillation counting.

Proteins from input, unbound and bound fractions were obtained from material in the organic phase of the first phenol/chloroform extraction of each sample (27). Carrier protein (5 µg bovine serum albumin), 0.01 vol. 10 M H2SO4 and 12 vol. acetone were added to precipitate protein at -70°C. After centrifugation protein pellets were washed in acidified acetone (1:6 100 mM H2SO4:acetone) and three times in dry acetone. Equal amounts of histone H4 were loaded on 15% SDS-containing polyacrylamide gels. Resolved proteins were transferred to Hybond-C nitrocellulose (Amersham) and histone H4 was detected by enhanced chemiluminescence (Amersham), as described previously (18,23).

Slot-blot analysis and Southern hybridizations

DNA samples were diluted in 0.6 M NaCl to equalize [3H]thymidine counts, heat denatured at 95°C for 10 min and cooled on ice for 5 min. Small aliquots were taken at this point to retest [3H]thymidine counts. A series of five serial doubling dilutions in ice-cold 2 M ammonium acetate was then carried out for each sample. Aliquots (200 µl) of each sample dilution were loaded in duplicate onto Hybond N+ nylon membranes (Amersham) using a slot-blot manifold (BioRad). All slots were washed with 1 M ammonium acetate before fixing the DNA on the filter with 0.4 M NaOH.

Hybridizations, with either end-labelled oligonucleotides or random primed DNA fragments, were performed as described previously (23) using standard procedures (26). The intensities of labelled slots were quantified using a PhosphorImager (Molecular Dynamics). Labelled membranes were stripped with boiling 0.5% SDS, followed by gradual cooling to room temperature. Membranes could be labelled and stripped ~10 times without significant loss of signal.

DNA probes

HGH 1 (human growth hormone 1), clone pHGH107, was obtained from the American Type Culture Collection (ATCC, reference no. 31538; US patent no. 4,342,832) and digested with HindIII and EcoRI to release a 591 bp cDNA fragment. ATCC literature cites the HGH 1 gene as a single copy gene at the cytogenetic location 17q22-q24. Telomeric DNA probe C36 [5'-(CCCTAA)6-3'] was a gift from Dr Titia de Lange (Rockefeller University, New York, NY). The remaining oligonucleotide probes were as follows: heterochromatin probes het266 [5'-(CCATT)6-3'], het405 (5'-GAA GAA GCT TTC TGA GAA ACT GCT TAG TG-3') and het527 (5'-TCC AAA GCC CAT GTA GGC CGA GCC AAG ACA AGA GT-3'); SINE (Alu family consensus sequence) probe Alu450 (5'-AAA GTG CTG GGA TTA CAG G-3'); LINE (KpnI family consensus sequence) probe Line B201 (5'-CAT GGC ACA TGT ATA CAT ATG TAA CWA ACC-3'). CpG island probe M2 was made from total human DNA selected on an MeCP2 column (28) and was a gift from Dr Sally Cross (Edinburgh University, UK).

Quinoline oxidoreductase (GenBank accession no. L13278) and p130/Rb-like protein 2 (GenBank accession no. X74594) are genes that we have mapped to pericentric heterochromatin of human chromosomes 1 and 16 respectively (cytogenetic locations 1q12 and 16q12). The GDBtm Human Genome Database version 6.0 (29) was used to query the location of cytogenetic regions 1q12 and 16q12 on an integrated linkage map (accessed on the World Wide Web at URL: http://gdbwww.gdb.org/jmqp/queryByPosn.html). The range of linkage markers for each cytogenetic region was used to identify candidate, single copy genes with the integrated gene map (30) at http://www.ncbi.nlm.nih.gov/SCIENCE96/. IMAGE consortium cDNA clones of EST sequences (31) of the quinoline oxidoreductase and p130 genes, identified by IMAGE Consortium (Lawrence Livermore National Laboratory, CA) clone ID nos 489645 and 612408 and GenBank accession nos AA099529 and AA179202, were obtained from the UK Human Genome Mapping Project (HGMP) Resource Centre, Hinxton, Cambridge. The cDNA inserts from these clones were excised with EcoRI/NotI or EcoRI/XhoI to give fragments of size 456 and 462 bp, for quinoline oxidoreductase and p130 respectively. These probes both gave clean single bands by Southern analysis of restricted genomic DNA.

An EST was also identified for the human 28S rRNA gene (GenBank accession no. M11167) with IMAGE Consortium (LLNL) clone ID no. 342765. The insert of 414 bp was excised with EcoRI/NotI. All other DNA probes were as described previously (23).

RESULTS

Immunoprecipitation results in selective enrichment of acetylated chromatin

Chromatin was prepared by limited micrococcal nuclease digestion of isolated nuclei. A pool of the first supernatant (S1) and the solubilized chromatin fraction (S2; see Materials and Methods) formed the input material for each immunoprecipitation experiment. The conditions of nuclease digestion were adjusted to give a high yield of soluble chromatin (78% of total DNA on average) while at the same time minimizing the possibility of selectively destroying the most nuclease-sensitive chromatin domains. The chromatin recovered by this procedure contained a high proportion of oligonucleosomes (Fig. 1).


Figure 1. Size distribution of DNA isolated from input, unbound and bound chromatin fractions. Oligonucleosome fragments from input chromatin (IN) were immunoprecipitated with antibody R232 (specific to H4Ac8) or incubated without antibody (N/A). DNA was isolated from input, antibody-unbound (UN) or -bound (BD) fractions and resolved on a 1.2% agarose gel stained with ethidium bromide. The marker is a 123 bp ladder (Gibco BRL).

Soluble chromatin was immunoprecipitated with affinity-purified antibodies specific for H4 acetylated at particular lysine residues (i.e. R13/16, R20/12, R232/8 and R41/5; the second number denotes the acetylated lysine residue recognized). H4 lysines are acetylated in a specific order in mammalian cells (16). In bulk chromatin lysine 16 is acetylated in all acetylated H4 isoforms, of which the mono-acetylated isoform (H4Ac1) is by far the most frequent (32). Lysines 8 and 12 are acetylated only in the di-, tri- and tetra-acetylated isoforms (H4Ac2-4), while lysine 5 is acetylated only in the tri- and tetra-acetylated forms. Because of this, antibodies to H4Ac16 are expected to immunoprecipitate chromatin fragments containing any acetylated H4 isoform, while R41/5 will precipitate only those containing the most highly acetylated forms. There will be exceptions to this general rule. For example, chromatin that is newly assembled after DNA replication is enriched in H4 acetylated specifically at lysines 5 and 12 (33). However, as this deposition-related pattern of acetylation persists for only a few minutes after DNA replication (33 and references therein), it is unlikely to significantly influence the pattern of acetylation across any particular region.

The efficiency of immunoprecipitation of the oligonucleosomes in input material was determined by quantifying the amount of [3H]thymidine-labelled DNA in the unbound and bound fractions (Table 1). The total amount of material recovered after immunoprecipitation was, on average, 53% of the input material, while recovery of chromatin in the bound fraction varied with the antibody used. The percentage of recovered DNA in the bound fraction correlated with the expected frequency of histone H4 acetylation in bulk chromatin (i.e. H4Ac16 > H4Ac8,12 > H4Ac5). Thus antiserum R13/16, which recognizes all acetylated isoforms, precipitated more material than R41/5, which recognizes only the relatively rare tri- and tetra-acetylated isoforms.

DNA and proteins were isolated from the antibody-bound, -unbound and input fractions and analysed, respectively, by agarose gel electrophoresis, SDS-PAGE and Western blotting. For each experiment almost all the acetylated H4 recognized by the precipitating antibody was found in the bound fraction and very little in the unbound (Fig. 1B, lane 2). As noted previously by ourselves (23) and others (34), the DNA in a typical antibody-bound fraction was selectively enriched in longer oligonucleosomes (Fig. 1, compare lanes 3 and 4) and in histone H1 (Fig. 2A, lane 5). The reasons for this are unclear but are unlikely to be attributable to cross-reaction of the anti-AcH4 antibodies with H1 or to non-specific antibody binding. No evidence for such cross-reaction is seen on Western blots (data not shown) nor is there any consistent difference in the size of the chromatin fragments precipitated by the different antibodies. If cross-reaction were a significant problem then differences between antisera would be expected. Minimal precipitation occurred in the absence of antibodies or with preimmune antibodies, though we cannot exclude the possibility that larger fragments are pulled down through entrapment within immune complexes formed by genuine (i.e. specific) antibody-antigen reactions. However, the close correlation between the amount of chromatin precipitated by the different antibodies and that expected on the basis of the known frequency of acetylation at different H4 lysines (Table 1) strongly indicates that non-specific precipitation, however caused, is not a significant problem.


Figure 2. Analysis of proteins afer immunoprecipitation. (A) Proteins from input, unbound and bound fractions were isolated after immunoprecipitation in the absence of antibody (N/A) or in the presence of antibody R232. Core histones were resolved by 15% SDS-PAGE and stained with Coomassie blue. The amount of H4 in each fraction was quantified by scanning densitometry of each track. The marker is total acid-extracted histones from a human cell line. (B) Equal amounts of H4 from the input, unbound and bound fractions from immunoprecipitation experiments [calculated by densitometry, see (A)] were resolved by 15% SDS-PAGE. Western blotting and immunostaining with the appropriate antibody showed enrichment of H4 in the bound fraction. Immunocomplexes were detected by enhanced chemiluminesence (Amersham).

Table 1. Precipitation of chromatin with antibodies to acetylated H4 isoforms
Antiserum Specificity Chromatin precipitated (% input DNA)
R13/16 H4Ac16 14.7 ± 4.2 (n = 2)
R20/12 H4Ac12 11.2 ± 1.7 (n = 2)
R232/8 H4Ac8 8.8
R41/5 H4Ac5 1.6
No antibody   0.4 ± 0.07 (n = 4)
Chromatin from cultured human lymphoblastoid cells was immunoprecipitated with affinity-purified antibodies to acetylated H4 as described in the text. Input chromatin was radiolabelled by growing cells for 16-18 h prior to harvesting in medium containing [3H]thymidine. DNA recovery was monitored by scintillation counting. Overall recovery after immunoprecipitation and DNA isolation from antibody-bound and -unbound fractions was 50-60%.

Equal amounts of DNA (based on [3H]thymidine counts) from the input, unbound and bound fractions were applied to nylon membranes by slot blotting. All samples were applied as at least four doubling dilutions in duplicate. The filters were hybridized to 32P-labelled oligonucleotides or DNA fragments corresponding to various coding and non-coding sequences and the level of hybridization quantified by phosphorimaging. The same filters were stripped and reprobed several times with different probes, so the results for each probe are directly comparable. The labelling intensity of the bound DNA divided by that of the unbound DNA (i.e. the bound/unbound ratio) was used as a measure of the level of acetylation of H4 associated with specific DNA sequences. A bound/unbound (B/U) ratio of 1 indicates that the sequence is distributed equally between acetylated and non-acetylated chromatin. This level of acetylation is equivalent to that of the input (unfractionated) chromatin. Values >1 indicate relatively increased acetylation and values <1 represent depletion.

H4 acetylation associated with coding DNA in euchromatin

H4 acetylation along five representative pol II transcribed genes was tested. As shown in Table 2, acetylation of H4Ac16 was slightly increased in all cases (average B/U 1.47) whereas acetylation of lysines 5, 8 and 12 was the same as that of input chromatin (average B/U 0.99). Significantly, there was no correlation between the level of H4 acetylation and transcriptional activity of the genes tested. Bound/unbound ratios were the same in constitutively active genes ([alpha]-tubulin and c-myc) and silent genes ([beta]-globin, proinsulin and hgh). In addition, there were no significant differences between acetylation along these coding regions and that in CpG islands (Table 3), which supports our previous study of H4 acetylation in the CpG island, promoter and coding regions of the c-myc gene (23). A very similar pattern of H4 acetylation (at least at lysines 8 and 16) was also seen in association with the transcriptionally hyperactive pol I transcribed 28S rRNA genes. The 28S rRNA genes are arranged in tandem repeats at the secondary constrictions of acrocentric chromosomes, which form the nucleolar organiser region (NOR) in interphase nuclei. These regions stain as strongly as other regions of euchromatin, but no more so, in metaphase chromosome spreads (A.M.Keohane and B.M.Turner, unpublished observations).

H4 acetylation associated with simple repeat DNA and coding DNA within or adjacent to such repeats

Simple repeat sequences characteristic of different types of constitutive heterochromatin were generally associated with low levels of H4 acetylation. However, the level varied from one repeat to another and, to a lesser extent, from one H4 lysine to another. All three sequences located in constitutive heterochromatin were associated with H4 that was underacetylated at all four lysines, with the core satellite III sequence showing the lowest acetylation and a Sau3A sequence the greatest (Table 3). Acetylation of H4 associated with the simple telomeric repeat (CCTTAA)n at lysine 16 was equivalent to that in coding regions, but slightly reduced at lysines 5, 8 and 12 (Table 3). Thus a general underacetylation of H4 is not a property of all types of chromatin containing simple sequence repeat DNA.

Table 2. Levels of acetylated H4 associated with genes in euchromatin transcribed by pol II
Acetylated H4 isoform Euchromatin (pol II) genes
  c-myc [beta]-globin pro-insulin hgh [alpha]-tubulin Average SD
H4Ac16   (i) 1.30 1.28 1.15 1.41 1.43 1.31 0.11
(ii) 1.55 1.49 1.93 ND 1.65 1.66 0.21
H4Ac12   (i) 0.93 0.69 0.91 ND ND 0.84 0.13
(ii) 0.89 0.90 1.04 1.18 1.09 1.02 0.12
H4Ac8 0.95 1.12 1.04 1.12 0.91 1.03 0.10
H4Ac5 1.17 1.14 0.88 ND 0.93 1.03 0.15
Amounts of each specific DNA sequence in the antibody-bound (i.e. acetylated) and -unbound fractions after immunoprecipitation with antibodies to acetylated H4 were determined by slot-blotting. Values in the table represent the ratio between the amount of each sequence in the antibody-bound and -unbound fractions. Values >1 indicate enrichment in acetylated H4 relative to bulk chromatin while values <1 indicate depletion. Rows labelled (i) and (ii) are results from separate experiments.

Table 3. Relative levels of H4 acetylation associated with different regions of the human genome
Acetylated H4 Pol II genes CpG islands Pol I gene Simple repeat sequences Heterochromatin genes SINEs LINEs
isoform (average)   28S rRNA sat III
(het266)
alphoid [beta]/Sau3
(het405)
telomere
(C-36)
QOR p130/Rb-like Alu
family
KpnI
family
H4Ac16      (i) 1.31 1.30 0.97 0.15 0.38 ND 1.24 1.39 1.07 1.36 0.70
(ii) 1.66 1.98 1.58 0.27 0.56 0.86 1.62 1.81 ND 1.53 1.08
H4Ac12      (i) 0.84 1.53 ND 0.34 0.31 ND 0.62 0.56 ND 0.92 ND
(ii) 1.02 0.87 ND 0.43 0.68 0.82 ND 0.71 0.69 1.36 0.76
H4Ac8 1.03 1.11 0.96 0.38 0.28 0.26 0.89 0.95 0.81 1.49 0.67
H4Ac5 1.03 0.72 ND 0.17 0.57 0.53 0.81 0.47 ND 1.38 0.82
Figures in the Table are the antibody-bound/-unbound ratios after immunoprecipitation with antibodies to acetylated H4 (see text and Table 2 legend). Average values for five pol II genes are taken from Table 2. Values >1 indicate enrichment in acetylated H4 relative to bulk chromatin while values <1 indicate depletion. Rows labelled (i) and (ii) are results from separate experiments.

The genes coding for quinoline oxidoreductase and p130/Rb-like protein map by linkage to regions within or adjacent to the blocks of heterochromatin at 1q12 and 16q12 (see Materials and Methods). These genes showed levels of acetylation at lysines 5, 8 and 12 that were (collectively) significantly below that of the five euchromatic pol II coding regions tested (Table 3, P < 0.001). Levels of acetylation at H4 lysine 16 were the same. This result suggests that these putative heterochromatin genes are depleted in the more highly acetylated H4 isoforms but retain a level of mono-acetylated H4 (the major isoform detected by R13/16) similar to that of euchromatic genes.

SINE-rich and LINE-rich chromatin differ in H4 acetylation

Moderately repetitive interspersed sequences are common in mammalian genomes. They are classified as either short interspersed repetitive sequences (SINES) or long interspersed repetitive sequences (LINES) (35,36). The major human LINES and SINES are the L1 (or KpnI) family of sequences and the Alu family of sequences respectively (37). Both sequences are mobile genetic elements that have arisen by the process of retroposition and both can be transcribed into RNA. Oligonucleotides complementary to the consensus sequences of these repetitive elements were used as probes in immunoprecipitation experiments. The results (Fig. 3 and Table 3) show that SINES are relatively enriched in chromatin containing H4 acetylated at lysines 5, 8 and 12 compared with coding DNA (B/U ratios 1.29 ± 0.25, n = 4 and 0.99 ± 0.13, n = 17 respectively, P < 0.01), but not in chromatin acetylated at H4 lysine 16 (B/U ratios 1.45, n = 2 and 1.47 ± 0.23, n = 9 respectively). In contrast, LINE elements are relatively depleted in chromatin acetylated at any of the four acetylatable H4 lysines, including lysine 16, in comparison with coding DNA (B/U ratios 0.81 ± 0.16, n = 5, and 1.16 ± 0.28, n = 26 respectively, P < 0.02). The results indicate an increase in the most highly acetylated H4 isoforms (i.e. H4Ac2-4) in SINE-rich regions of the genome and an overall reduction in H4 acetylation in LINE-rich regions.


Figure 3. Slot-blot analysis of DNA after immunoprecipitation. DNA was isolated from input, unbound and bound fractions after immunoprecipitation with antibody R232. Equal amounts of DNA, based on the counts of incorporated [3H]thymidine, were loaded in duplicate onto Hybond N+ nylon membranes (Amersham). Five serial doubling dilutions were loaded, only one of which is shown (as indicated underneath each panel). The same membrane was used for labellings with the various indicated probes (see Materials and Methods).

DISCUSSION

Specificity of histone acetylation in human chromatin

Indirect immunofluorescence microscopy has been used to define the distribution of acetylated histones along mammalian metaphase chromosomes. The distribution is strikingly non-random. Centric heterochromatin and the blocks of heterochromatic DNA on the proximal long arms of chromosomes 1, 9 and 16 and on Yq are marked by very low levels of acetylation of all four core histones (19). In contrast, alternating brightly and weakly fluorescent bands are seen along the chromosome arms and correspond, in general terms, to R bands and G bands respectively (38). In female cells the inactive X chromosome (Xi) is also underacetylated throughout its length, with the exception of the pseudoautosomal region at Xp22 and two other narrow bands (20) which remain brightly fluorescent in metaphase chromosomes. In all studies so far antisera to the acetylated isoforms of all four core histones and to H4 acetylated at one or other of lysines 5, 8, 12 and 16 have all given similar, though not always identical, results (20, 21). As yet immunofluorescence analysis of mammalian chromosomes has not revealed any examples of histone-specific or lysine-specific acetylation comparable with the localization in Drosophila of H4Ac16 on the male X chromosome or H4Ac12 on centric [beta]-heterochromatin (18).

However, while the immunofluorescence approach can define the broad distribution of histone acetylation across metaphase chromosomes and can provide a rapid and accurate assessment of H4 acetylation in both normal and aberrant chromosomes (39), it lacks the resolution necessary to determine levels of acetylation along specific genes or at levels below that of the chromosome band. It is also applicable only to mitotic (primarily metaphase) chromosomes, raising the possibility that the patterns seen may be peculiar to this rather unrepresentative phase of the cell cycle. The immunoprecipitation approach addresses both these limitations by providing resolution at the single gene level (or below) and, more importantly, by being applicable to cells at all stages of the cell cycle.

The results presented here provide two indications that lysine-specific H4 acetylation may be involved in the regulation of mammalian chromatin. The first is the modest but consistent increase in H4Ac16 on all types of coding DNA, which presumably reflects an increase in the level of mono-acetylated H4 in these regions. It is interesting to note that in the yeast Saccharomyces cerevisiae, of the four acetylatable H4 lysines, lysine 16 is the only one whose acetylation can, on its own, prevent silencing of the mating type genes (40,41 and references therein). Both of these observations suggest that H4 lysine 16 has a pivotal role in determining the potential of coding DNA for expression or silencing. The second indication comes from the variation in patterns of H4 acetylation on different types of heterochromatin. For example, H4 associated with satellite III sequences (probe het266), present in the centric heterochromatin of several human chromosomes (42), is underacetylated at all four lysines. In contrast, the sequences recognized by probe het527, which are found in some major blocks of [beta]-heterochromatin, particularly those adjacent to the simple sequence DNA satellite III (het266) contained in the centromeric chromatin of chromosome 9 (43), are strongly underacetylated at lysine 8, but show levels of acetylation only slightly below those of euchromatin at lysines 12 and 16. Such differences cannot easily be explained by shifts in the relative amounts of the mono-acetylated and more highly acetylated isoforms and suggest that regional differences in the levels of H4Ac1 and H4Ac2-4 are overlaid with more subtle lysine-specific differences. They are more consistent with the possibility that lysine-specific acetylation plays a role in packaging of different types of heterochromatic DNA, perhaps analogous to that played by H4 lysine 12 acetylation in D.melanogaster (18) and S.cerevisiae (44).

At first sight the variation in lysine-specific H4 acetylation associated with [beta]-heterochromatin seems to be only partly consistent with the observation that in metaphase chromosome spreads the heterochromatin block on chromosome 9 labels weakly with antisera to all acetylated H4 isoforms (19; B.M.Turner, unpublished observations). A likely explanation is that levels of acetylation on certain types of heterochromatin are reduced as cells enter mitosis. This suggestion is consistent with the general deacetylation of core histones as cells enter mitosis (45) and with the observation that levels of acetylation along heterochromatin can vary as cells differentiate (23) and move through the cell cycle (L.P.O'Neill and B.M.Turner, unpublished observations).

Histone acetylation in coding and non-coding regions

We have shown previously by immunoprecipitation of chromatin from the aneuploid human cell line HL60 that there is no correlation between the overall level of histone acetylation and actual or potential transcriptional activity (23). This result is confirmed by the present experiments. All five pol II coding regions tested showed the same pattern of H4 acetylation irrespective of their transcriptional status, namely levels of acetylation at H4 lysines 5, 8 and 12 that were indistinguishable from those in bulk chromatin and a relative increase in acetylation at lysine 16. The latter is consistent with a selective increase in the mono-acetylated isoform, H4Ac1. The same pattern of H4 acetylation was also seen in the single pol I gene tested, namely that encoding 28S rRNA. Thus the euchromatin genes tested showed a remarkably consistent pattern of H4 acetylation, despite having rather different chromatin environments: [beta]-globin lacks a CpG island and maps within a G band, while the other four pol II genes are all R band genes that are associated with a CpG island (46,47). The results suggest that the pattern of histone acetylation along coding regions is, at least in euchromatin, independent of the surrounding chromatin. This was tested further by examining two genes that map within or adjacent to the large blocks of heterochromatin at 1q12 and 16q12. These genes were found to retain the relative enrichment in H4Ac16 characteristic of coding regions, but to show a significant drop in acetylation at lysines 5, 8 and 12 (presumably reflecting a relative depletion in hyperacetylated H4). It is tempting to speculate that depletion of the more highly acetylated H4 isoforms in these genes is due to their proximity to underacetylated heterochromatin, while their relatively high level of acetylation at H4 lysine 16 is necessary to maintain their transcriptional competence. Testing of additional genes that map within or adjacent to heterochromatin will show whether or not this is a general rule.

R bands are characterized by being relatively rich in coding DNA, GC base pairs, SINE sequences and acetylated H4, while being relatively poor in LINE sequences. G bands, in contrast, are relatively poor in coding DNA, SINES and acetylated H4 but are rich in LINES and AT base pairs (46,47). A correlation has been noted between SINE density and gene density along the human genome, with T bands being particularly rich in both genes and SINES (48). This correlation may reflect the tendency of SINES to be located within introns (47). The results presented here suggest that the relatively high level of hyperacetylated H4 (i.e. the di-, tri, and tetra-acetylated isoforms) detected by immunofluorescence at R bands in general (20), and T bands in particular (38), is attributable more to their relatively high SINE density than to high levels of coding DNA itself.

It was the aim of the immunoprecipitation experiments described here to define the steady-state patterns of H4 acetylation across defined regions of the human genome. In order to do this we used a combination of nuclease digestion and solubilization conditions that minimized the possibility of selective DNA loss while still giving a high yield of soluble chromatin, usually ~80%. Earlier studies, with a rather different objective, namely to compare the structure and composition of transcriptionally active and inactive chromatin fractions, consistently used highly selected chromatin subfractions comprising only a small proportion of total chromatin (34,49). We suggest that the use of such very different starting chromatin preparations is a likely explanation for the fact that some previous experiments, unlike those reported here or earlier by us (23), have shown that chromatin fractions containing high levels of acetylated histones are also enriched in transcribed or transcribable genes. Such differences may indeed exist within highly selected chromatin subfractions, but may not be present when the experiment is carried out with essentially unselected, bulk chromatin. The lack of correlation between acetylation and transcriptional status noted here cannot easily be attributed to deficiencies in the immunoprecipitation procedure. The clear correlation between the amount of chromatin precipitated by each antibody and the relative frequencies of acetylation of H4 lysines 5, 8, 12 and 16 (Table 1) is a strong argument against the existence of excess non-specifically bound material in the antibody-bound fraction. In addition, non-specific chromatin precipitation cannot explain the finding that a large proportion of coding DNA, irrespective of transcriptional status, remains in the unbound fraction, despite almost complete precipitation of acetylated H4 (Fig. 2).

These considerations are also relevant to the initially puzzling finding that chromatin immunoprecipitated with antibodies to acetylated H4 is consistently enriched in larger oligonucleosomes. This apparently runs counter to the generally accepted idea that more highly acetylated chromatin fractions are more susceptible to nuclease digestion. In fact, the relationship between histone acetylation and the rate of digestion with micrococcal nuclease is complex. While it appears to be the case that, in some cells at least, a small chromatin fraction is both highly acetylated and relatively rapidly digested with micrococcal nuclease (see for example 50 and references therein), the same experiments show that a significant proportion of highly acetylated chromatin is not rapidly digested. In fact, in one fractionation scheme chromatin that remained in the pellet after digestion, presumably the most nuclease resistant, was just as enriched in highly acetylated H4 as the most rapidly digested S1 fraction (50). It should also be noted that in some experiments setting out to analyse the relationship between histone acetylation and nuclease sensitivity levels of histone acetylation were enhanced by exposure of growing cells to deacetylase inhibitors such as sodium butyrate (51,52). Treatments that result in artificial overall histone hyperacetylation may create relationships that do not exist in untreated cells (50). So, while we cannot yet completely exclude the possibility that enrichment of the antibody-bound fraction in larger oligonucleosomes is an artefact of the experimental protocol, it is also possible that it reflects the existence of an acetylated but micrococcal nuclease-resistant chromatin fraction. Experiments to test this are in progress.

ACKNOWLEDGEMENTS

This work was supported by grants from the Wellcome Trust (045030/Z/95) and the BBSRC (CAD04371). We thank Dr Wendy Bickmore and Dr Sally Cross for supplying DNA probes and Jayne Lavender for expert help with cell culture.We acknowledge the UK Human Genome Mapping Project Resource Centre, who provided services and materials including IMAGE Consortium (LLNL) cDNA clones.

REFERENCES

1 Wolffe,A.P. (1992) Chromatin: Structure and Function. Academic Press Inc., San Diego, CA.

2 Grunstein,M. (1990) Annu. Rev. Cell Biol., 6, 643-678. MEDLINE Abstract

3 Paranjape,S.M., Kamakaka,R.T. and Kadonaga,J.T. (1994) Annu. Rev. Biochem., 63, 265-297. MEDLINE Abstract

4 Kingston,R.E., Bunker,C.A. and Imbalzano,A.N. (1996) Genes Dev., 10, 905-920. MEDLINE Abstract

5 Kornberg,R.D. and Lorch,Y. (1995) Curr. Opin. Cell Biol., 7, 371-375. MEDLINE Abstract

6 Wu,R.S., Panusz,H.T., Hatch,C.L. and Bonner,W.M. (1984) CRC Crit. Rev. Biochem., 20, 201-263.

7 Bradbury,E.M. (1992) BioEssays, 14, 9-16. MEDLINE Abstract

8 Brownell,J.E., Zhou,J., Ranalli,T., Kobayashi,R., Edmondson,D.G., Roth,S.Y. and Allis,C.D. (1996) Cell, 84, 843-851. MEDLINE Abstract

9 López-Rodas,G., Tordera,V., Sánchez del Pino,M.M. and Franco,L. (1990) J. Biol. Chem., 264, 19028-19033.

10 Brosch,G., Goralik-Schramel,M. and Loidl,P. (1996) FEBS Lett., 393, 287-291. MEDLINE Abstract

11 Kleff,S., Andrulis,E.D., Anderson,C.W. and Sternglaz,R. (1995) J. Biol. Chem., 270, 24674-24677. MEDLINE Abstract

12 Taunton,J., Hassig,C.A. and Schreiber,S.L. (1996) Science, 272, 408-411. MEDLINE Abstract

13 Turner,B.M. (1993) Cell, 75, 5-8. MEDLINE Abstract

14 Turner,B.M., Belyaev,N.D., Keohane,A.M., Lavender,J.S. and O'Neill,L.P. (1995) In Brandham,P.E. and Bennett,M.D. (eds), Kew Chromosome Conference IV. Royal Botanic Gardens, Kew, UK, pp. 339-350.

15 Chang,L., Loranger,S.S., Mizzen,C., Ernst,S.G., Allis,C.D. and Annunziato,A.T. (1997) Biochemistry, 36, 469-480. MEDLINE Abstract

16 Turner,B.M., O'Neill,L.P. and Allan,I.M. (1989) FEBS Lett., 253, 141-145. MEDLINE Abstract

17 Turner,B.M. and Fellows,G. (1989) Eur. J. Biochem., 179, 131-139. MEDLINE Abstract

18 Turner,B.M., Birley,A.J. and Lavender,J. (1992) Cell, 69, 375-384. MEDLINE Abstract

19 Jeppesen,P., Mitchell,A., Turner,B.M. and Perry,P. (1992) Chromosoma, 100, 3222-3232.

20 Jeppesen,P. and Turner,B.M. (1993) Cell, 74, 281-289. MEDLINE Abstract

21 Belyaev,N.D., Keohane,A.M. and Turner,B.M. (1996) Hum. Genet., 97, 573-578.

22 Bone,J.R., Lavender,J., Richman,R., Palmer,M.J., Turner,B.M. and Kuroda,M.I. (1994) Genes Dev., 8, 96-104. MEDLINE Abstract

23 O'Neill,L.P. and Turner,B.M. (1995) EMBO J., 14, 3946-3957. MEDLINE Abstract

24 Rooney,C.M., Gregory,C.D., Rowe,M., Finerty,S., Edward,C., Rupari,H. and Rickinson,A.B. (1986) J. Natl. Cancer Inst., 77, 681-687. MEDLINE Abstract

25 Walls,E.V. and Crawford,D.H. (1987) In Klaus,G.C.B. (ed.), Lymphocytes: A Practical Approach. IRL Press, Washington, DC, pp. 149-162.

26 Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

27 Matthews,C.G.P., Goodwin,G.H. and Johns,E.W. (1979) Nucleic Acids Res., 6, 167-179.

28 Cross,S.H., Charlton,J.A., Nan,X.S. and Bird,A.P. (1994) Nature Genet., 6, 236-244. MEDLINE Abstract

29 Fasman,K.H., Letovsky,S.I., Li,P., Cottingham,R.W. and Kingsburt,D.T. (1997) Nucleic Acids Res., 25, 72-80. MEDLINE Abstract

30 Schuler,G.D. et al. (1996) Science, 274, 540-567. MEDLINE Abstract

31 Lennon,G.G., Auffray,C., Polymeropoulos,M. and Soares,M.B. (1996) Genomics, 33, 151-152.

32 Thorne,A.W., Kmiciek,D., Mitchelson,K., Sautiere,P. and Crane-Robinson,C. (1990) Eur. J. Biochem., 193, 701-713. MEDLINE Abstract

33 Sobel,R.E., Cook,R.G., Perry,C.A., Annunziato,A.T. and Allis,C.D. (1995) Proc. Natl. Acad. Sci. USA, 92, 1237-1241. MEDLINE Abstract

34 Hebbes,T.R., Thorne,A.W. and Crane-Robinson,C. (1988) EMBO J., 7, 1396-1402.

35 Singer,M.F. (1982) Cell, 28, 433-434. MEDLINE Abstract

36 Tyler-Smith,C. and Willard,H.F. (1993) Curr. Opin. Genet. Dev., 3, 390-397. MEDLINE Abstract

37 Korenberg,J. and Rykowski,M. (1988) Cell, 53, 391-400. MEDLINE Abstract

38 Jeppesen,P. (1997) BioEssays, 19, 67-74. MEDLINE Abstract

39 Migeon,B.R., Luo,S., Jani,M. and Jeppesen,P. (1994) Am. J. Hum. Genet., 55, 497-504. MEDLINE Abstract

40 Grunstein,M. (1997) Nature, 389, 349-352 MEDLINE Abstract

41 Braunstein,M., Rose,A.B., Holmes,S.G., Allis,C.D. and Broach,J.R. (1993) Genes Dev., 7, 592-604. MEDLINE Abstract

42 Gosden,J., Hanratty,D., Starling,J., Fantes,J., Mitchell,A. and Porteous,D. (1991) Cytogenet. Cell Genet., 57, 100-104. MEDLINE Abstract

43 Mitchell,A., Jeppesen,P., Hanratty,D. and Gosden,J. (1992) Chromosoma, 101, 333-341. MEDLINE Abstract

44 Braunstein,M., Sobel,R.E., Allis,C.D., Turner,B.M. and Broach,J.R. (1996) Mol. Cell. Biol., 16, 4349-4356. MEDLINE Abstract

45 d'Arma,J.A., Gurley,L.R. and Tobay,R.A. (1983) Exp. Cell Res., 147, 407-417. MEDLINE Abstract

46 Craig,J.M. and Bickmore,W.A. (1993) BioEssays, 15, 349-354. MEDLINE Abstract

47 Holmquist,G.P. (1992) Am. J. Hum. Genet., 51, 17-37. MEDLINE Abstract

48 Saccone,S., Caccio,S., Kusuda,J., Andreozzi,L. and Bernardi,G. (1996) Gene, 174, 85-94. MEDLINE Abstract

49 Allegra,P., Sterner,R., Clayton,D.F. and Allfrey,V.G. (1987) J. Mol. Biol., 196, 379-388. MEDLINE Abstract

50 Nelson,D., Covault,J. and Chalkley,R. (1980) Nucleic Acids Res., 8, 1745-1763. MEDLINE Abstract

51 Simpson,R.T. (1978) Cell, 13, 691-699. MEDLINE Abstract

52 Vidali,G., Boffa,L.C., Bradbury,E.M. and Allfrey,V.G. (1978) Proc. Natl. Acad. Sci. USA, 75, 2239-2243. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +44 121 414 6824; Fax: +44 121 414 6815; Email b.m.turner@bham.ac.uk


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk
Last modification: 6 Feb 1998
Copyright© Oxford University Press, 1998.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
P. Kapoor-Vazirani, J. D. Kagey, D. R. Powell, and P. M. Vertino
Role of hMOF-Dependent Histone H4 Lysine 16 Acetylation in the Maintenance of TMS1/ASC Gene Activity
Cancer Res., August 15, 2008; 68(16): 6810 - 6821.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. M. Gorisch, M. Wachsmuth, K. F. Toth, P. Lichter, and K. Rippe
Histone acetylation increases chromatin accessibility
J. Cell Sci., December 15, 2005; 118(24): 5825 - 5834.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Talasz, H. H. Lindner, B. Sarg, and W. Helliger
Histone H4-Lysine 20 Monomethylation Is Increased in Promoter and Coding Regions of Active Genes and Correlates with Hyperacetylation
J. Biol. Chem., November 18, 2005; 280(46): 38814 - 38822.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Sinkkonen, M. Malinen, K. Saavalainen, S. Vaisanen, and C. Carlberg
Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter
Nucleic Acids Res., April 29, 2005; 33(8): 2440 - 2451.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. G. Kemp, M. Ghosh, G. Liu, and M. Leffak
The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells
Nucleic Acids Res., January 13, 2005; 33(1): 325 - 336.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Swaminathan, E. M. Baxter, and V. G. Corces
The role of histone H2Av variant replacement and histone H4 acetylation in the establishment of Drosophila heterochromatin
Genes & Dev., January 1, 2005; 19(1): 65 - 76.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Sumer, R. Saffery, N. Wong, J. M. Craig, and K. H. A. Choo
Effects of Scaffold/Matrix Alteration on Centromeric Function and Gene Expression
J. Biol. Chem., September 3, 2004; 279(36): 37631 - 37639.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
N. Rizzi, M. Denegri, I. Chiodi, M. Corioni, R. Valgardsdottir, F. Cobianchi, S. Riva, and G. Biamonti
Transcriptional Activation of a Constitutive Heterochromatic Domain of the Human Genome in Response to Heat Shock
Mol. Biol. Cell, February 1, 2004; 15(2): 543 - 551.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Jiang, F. Yang, P. G. M. van Overveld, V. Vedanarayanan, S. van der Maarel, and M. Ehrlich
Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q
Hum. Mol. Genet., November 15, 2003; 12(22): 2909 - 2921.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Yu, N. Zingler, G. Schumann, and W. H. Stratling
Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription
Nucleic Acids Res., November 1, 2001; 29(21): 4493 - 4501.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Anguita, C. A. Johnson, W. G. Wood, B. M. Turner, and D. R. Higgs
Identification of a conserved erythroid specific domain of histone acetylation across the alpha -globin gene cluster
PNAS, September 26, 2001; (2001) 201413098.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. I. Gregory, T. E. Randall, C. A. Johnson, S. Khosla, I. Hatada, L. P. O'Neill, B. M. Turner, and R. Feil
DNA Methylation Is Linked to Deacetylation of Histone H3, but Not H4, on the Imprinted Genes Snrpn and U2af1-rs1
Mol. Cell. Biol., August 15, 2001; 21(16): 5426 - 5436.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Wan, K. Zhao, S. S. J. Lee, and U. Francke
MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome
Hum. Mol. Genet., May 1, 2001; 10(10): 1085 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Guy, C. Spalluto, A. McMurray, T. Hearn, M. Crosier, L. Viggiano, V. Miolla, N. Archidiacono, M. Rocchi, C. Scott, et al.
Genomic sequence and transcriptional profile of the boundary between pericentromeric satellites and genes on human chromosome arm 10q
Hum. Mol. Genet., August 12, 2000; 9(13): 2029 - 2042.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
A. L. Pelling, A. W. Thorne, and C. Crane-Robinson
A Human Genomic Library Enriched in Transcriptionally Active Sequences (aDNA Library)
Genome Res., June 1, 2000; 10(6): 874 - 886.
[Abstract] [Full Text]


Home page
ScienceHome page
R. H. Jacobson, A. G. Ladurner, D. S. King, and R. Tjian
Structure and Function of a Human TAFII250 Double Bromodomain Module
Science, May 26, 2000; 288(5470): 1422 - 1425.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. H. Waterborg
Steady-state Levels of Histone Acetylation in Saccharomyces cerevisiae
J. Biol. Chem., April 21, 2000; 275(17): 13007 - 13011.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. Schübeler, C. Francastel, D. M. Cimbora, A. Reik, D. I.K. Martin, and M. Groudine
Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta -globin locus
Genes & Dev., April 15, 2000; 14(8): 940 - 950.
[Abstract] [Ful